Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Brain (2)
- Humans (2)
- Pharmacists (2)
- Review Literature (2)
- Aggression (1)
-
- Alzheimer Disease (1)
- Analgesics (1)
- Antiemetics (1)
- Behavior (1)
- Cancer (1)
- Cannabinoids (1)
- Cannabis (1)
- Child (1)
- Child Development Disorders (1)
- Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; CFS/ME; DePaul College of Science and Health; Marcie Zinn; Mark Zinn; Leonard Jason; DePaul Center for Community Research; Qantitative Electroencephalography; qEEG; low-resolution electromagnetic tomography; LORETA; Centers for Disease Control and Prevention (1)
- Cognitive injury (1)
- Drug therapy (1)
- Food and Drug Administration (U.S.) (1)
- Glutamic Acid (1)
- Headache (1)
- Headache Disorders (1)
- Interpersonal Relations (1)
- Marijuana Smoking (1)
- Medicinal (1)
- Memantine (1)
- Mice (1)
- N-Methylaspartate (1)
- Pervasive (1)
- Plants (1)
- Quality of Life (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Memantine: Can It Be Used To Treat Children With Autism Spectrum Disorder?, Austin Brown, Katherine Liu, Pul Lee, Rachel Muhlenkamp, Manoranjan D'Souza
Memantine: Can It Be Used To Treat Children With Autism Spectrum Disorder?, Austin Brown, Katherine Liu, Pul Lee, Rachel Muhlenkamp, Manoranjan D'Souza
Pharmacy and Wellness Review
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairment in social, behavior and communicative skills. The current therapy for ASD only targets the associated symptoms such as aggression, self-harming acts or temper tantrums but not the core symptoms of social dysfunction. The pathology of ASD is not fully understood. Interestingly, imaging studies in ASD patients have reported abnormal high levels of glutamate in certain brain regions that play an important role in social interaction and communication. Thus, it has been hypothesized that medications attenuating glutamate transmission may be used as treatment for some of the core symptoms of …
Cannabinoids For The Treatment Of Chronic Headaches, Kevin Krivanek, Lucy K. Wagala, Brian Heilbronner, Kimberly Loughlin, David Kinder
Cannabinoids For The Treatment Of Chronic Headaches, Kevin Krivanek, Lucy K. Wagala, Brian Heilbronner, Kimberly Loughlin, David Kinder
Pharmacy and Wellness Review
Species of the Cannabis plant genus were among the earliest medicinal plants cultivated by man, with historical accounts of their medicinal uses dating back before the Common Era. Despite its current legal status, Cannabis has garnered nationwide attention as a therapeutic agent for various disease states, including chronic headaches, due to its medical indications as an antispastic, analgesic, antiemetic, neuroprotective and anti-inflammatory agent. Since headaches have a high prevalence in the American population and greatly impair simple daily aspects of living, chronic headaches have become a particular point of interest in regard to the therapeutic potential of Cannabis. Clinical trials …
Developing Drug Therapies: Cognitive Damage In Mice Following Brain Radiation, Rachel Yuska
Developing Drug Therapies: Cognitive Damage In Mice Following Brain Radiation, Rachel Yuska
The Journal of Purdue Undergraduate Research
Pediatric brain cancer patients are at a high risk for radiation-induced cognitive impairment due to white matter changes in the brain. Half of six-month radiotherapy survivors develop significant changes in white matter. Previous research has shown that a mouse model can be used to show similar cognitive and behavioral deficits in human patients. The purpose of this work is to evaluate the effectiveness of two drug therapies, Donepezil and 3,3-Diindolylmethane (DIM), that could be used to either protect the brain from radiation injury or cure the cognitive injury and behavioral deficits that result from whole-brain irradiation. This project consisted of …
The Myth Of "It's All In Your Head"
The Myth Of "It's All In Your Head"
DePaul Magazine
Researchers at DePaul's Center for Community Research are mapping the brain to uncover the causes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Psychologist Leonard Jason has been carrying out community-based epidemiology prevalence studies that show that about one million Americans, many of them from ethnic minorities, are afflicted with the condition.